P. Olbert

发表

Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis

A. Hartmann, H. Taubert, S. Wach, 2017, PloS one.

Assessing blood platelets as RNA biomarker source for prostate cancer

P. Olbert, J. Hänze, N. Timmesfeld, 2016, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[Gender-specific characteristics and survival of renal cell carcinoma].

P. Olbert, A. Schrader, Z. Varga, 2008, Der Urologe. Ausg. A.

Overweight is associated with improved cancer-specific survival in patients with organ-confined renal cell carcinoma

P. Olbert, A. Schrader, N. Timmesfeld, 2009, Journal of Cancer Research and Clinical Oncology.

Epithelial mesenchymal transition status is associated with anti-cancer responses towards receptor tyrosine-kinase inhibition by dovitinib in human bladder cancer cells

P. Olbert, J. Hänze, A. Hegele, 2013, BMC Cancer.

Prospective randomized Phase II trial of pegylated doxorubicin in the management of symptomatic hormone‐refractory prostate carcinoma

U. Engelmann, P. Olbert, A. Heidenreich, 2004, Cancer.

Current status and future perspectives of PSMA-targeted therapy in Europe: opportunity knocks

oNe mediciNe, M. Luster, C. Jilg, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

Immunostimulatory CpG Oligonucleotides Reduce Tumor Burden after Intravesical Administration in an Orthotopic Murine Bladder Cancer Model

K. Heeg, P. Olbert, P. Barth, 2005, Tumor Biology.

Plasma Levels of Cellular Fibronectin in Patients with Localized and Metastatic Renal Cell Carcinoma

P. Olbert, A. Heidenreich, J. Kropf, 2004, Tumor Biology.

Clinical significance of a prostate-specific antigen flare phenomenon in patients with hormone-refractory prostate cancer receiving docetaxel

P. Olbert, A. Heidenreich, A. Schrader, 2006, Anti-cancer drugs.

Pre- and perioperative predictors of short-term clinical outcomes in patients undergoing percutaneous nephrolitholapaxy

A. Scherag, P. Olbert, A. Schrader, 2007, Urological Research.

Second-line strategies for metastatic renal cell carcinoma: classics and novel approaches

P. Olbert, A. Schrader, Z. Varga, 2006, Journal of Cancer Research and Clinical Oncology.

Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis

P. Olbert, A. Heidenreich, A. Hegele, 2001, International journal of cancer.

Cellular fibronectin in patients with transitional cell carcinoma of the bladder

P. Olbert, A. Heidenreich, J. Kropf, 2003, Urological Research.

[Pelvic lymphadenitis after total hip arthroplasty : Mimicking of lymph node metastases in a patient with prostate cancer].

P. Olbert, A. Schrader, A. Hegele, 2010, Der Urologe. Ausg. A.

CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings.

P. Olbert, P. Barth, Z. Varga, 2010, Anticancer research.

Biochemical markers of bone turnover in patients with localized and metastasized prostate cancer

P. Olbert, A. Schrader, H. Wahl, 2007 .

Biochemical markers of bone turnover in patients with localized and metastasized prostate cancer.

P. Olbert, A. Schrader, H. Wahl, 2005, BJU international.

Antibodies after Botulinum Toxin A Injection into Musculus Detrusor Vesicae: Incidence and Clinical Relevance

P. Olbert, Z. Varga, A. Hegele, 2011, Urologia Internationalis.

Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit?

P. Olbert, J. Hänze, A. Hegele, 2014, BMC Urology.

[Metastasized renal cell carcinoma. Measurement of plasma levels of the tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib].

P. Olbert, A. Hegele, R. Hofmann, 2015, Der Urologe. Ausg. A.

Accuracy of frozen section examination of testicular tumors of uncertain origin.

P. Olbert, A. Heidenreich, P. Barth, 2002, European urology.

TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells.

P. Olbert, J. Hänze, C. Kesch, 2015, Urologic oncology.

Diagnosis and Therapy of Erectile Dysfunction Following Radical Prostatectomy

P. Olbert, A. Heidenreich, R. Hofmann, 2003 .

FACTOR XIII substitution in ulcerative colitis.

M. Classen, P. Olbert, R. Lorenz, 1995, The Lancet.

Lymphoceles Post-Radical Retropubic Prostatectomy: A Retrospective Evaluation of Epidemiology, Risk Factors and Outcome

P. Olbert, A. Hegele, R. Hofmann, 2015, Urologia Internationalis.

Laparoscopic Peritoneal Drainage of Symptomatic Lymphoceles after Pelvic Lymph Node Dissection Using Methylene Blue Instillation

P. Olbert, A. Schrader, Z. Varga, 2006, Urologia Internationalis.

[Toxicity and efficacy of intermittent docetaxel chemotherapy for hormone refractory prostate cancer].

P. Olbert, A. Schrader, A. Hegele, 2009, Aktuelle Urologie.

In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.

P. Olbert, A. Schrader, P. Barth, 2009, Anticancer research.

Antineoplastic effect of immunostimulatory DNA (CpG-ODN) in a murine C57-BL6/MB-49 transitional cell carcinoma model.

K. Heeg, P. Olbert, P. Barth, 2004, Anticancer research.

Clinical experience with a new ultrasonic and LithoClast combination for percutaneous litholapaxy

P. Olbert, S. Wille, Z. Varga, 2002, BJU international.

Comparison of a 20-Min Pad Test with the 1-Hour Pad Test of the International Continence Society to Evaluate Post-Prostatectomy Incontinence

P. Olbert, A. Schrader, A. Hegele, 2009, Urologia Internationalis.

CD34+ fibrocytes in chronic cystitis and noninvasive and invasive urothelial carcinomas of the urinary bladder

R. Moll, P. Olbert, W. Nimphius, 2007, Virchows Archiv.

Predictors of Spermatic Cord Torsion—Clinical Presentation and Intraoperative Findings

P. Olbert, Z. Varga, A. Hegele, 2011 .

Management of chronic testalgia by microsurgical testicular denervation.

U. Engelmann, P. Olbert, A. Heidenreich, 2002, European urology.

Efficacy and safety of the Accordion® stone-trapping device: in vitro results from an artificial ureterolithotripsy model

P. Olbert, A. Schrader, A. Hegele, 2010, Urological Research.

Y cacy and safety of the Accordion ® stone-trapping device : in vitro results from an arti W cial ureterolithotripsy model

P. Olbert, A. Schrader, A. Hegele, 2009 .

Experimental studies and first clinical experience with a new Lithoclast and ultrasound combination for lithotripsy.

P. Olbert, A. Heidenreich, Z. Varga, 2002, European urology.

Inguinal Fibrolipoma of the Spermatic Cord: Discrepancies between Clinical and Histopathological Findings

P. Olbert, A. Heidenreich, A. Hegele, 2003, Urologia Internationalis.

[Immunostimulatory CpG oligodeoxynucleotides (CpG-ODN) in an orthotopic murine transitional cell carcinoma (TCC) model. Effect on local cytokine expression].

P. Olbert, A. Schrader, A. Hegele, 2008, Der Urologe (Ausg. A).

TOT Approach in stress urinary incontinence (SUI) – outcome in obese female

P. Olbert, Z. Varga, A. Hegele, 2014, BMC Urology.

Transobturator tape ( TOT ) Approach in stress urinar y incontinence ( SUI ) – outcome in obese female

P. Olbert, Z. Varga, A. Hegele, 2013 .

[Transitional cell carcinoma of the bladder. Evaluation of plasma levels of cellular fibronectin as a stage-dependent marker].

P. Olbert, A. Schrader, J. Kropf, 2008, Der Urologe. Ausg. A.

Application of thalidomide/interleukin-2 in immunochemotherapy-refractory metastatic renal cell carcinoma

P. Olbert, A. Heidenreich, A. Schrader, 2005, Anti-cancer drugs.

[Fast-track concepts in the perioperative management of patients undergoing radical cystectomy and urinary diversion: review of the literature and research results].

P. Olbert, A. Schrader, A. Hegele, 2009, Der Urologe. Ausg. A.

The Influence of Body Mass Index on Outcomes in Ureteroscopy: Results from the Clinical Research Office of Endourological Society URS Global Study.

J. J. de la Rosette, P. Olbert, B. Onal, 2017, Journal of endourology.

[Extracorporeal shock wave lithotripsy].

A. Gross, C. Netsch, J. Rassweiler, 2018, Der Urologe. Ausg. A.

Incidence and long-term prognosis of papillary renal cell carcinoma

P. Olbert, A. Schrader, N. Timmesfeld, 2009, Journal of Cancer Research and Clinical Oncology.

[Management of geriatric patients with benign prostatic hyperplasia].

P. Olbert, M. Michel, S. Madersbacher, 2020, Der Urologe. Ausg. A.

Incidence and long term prognosis of papillary renal cell carcinoma.

P. Olbert, A. Schrader, A. Hegele, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Bladder cancer update: what was new at the 2010 annual congress of the German Association of Urology in Düsseldorf?].

S. Füssel, R. Knüchel, R. Nawroth, 2011, Der Urologe. Ausg. A.

Factor XIII in Chronic Inflammatory Bowel Diseases

P. Olbert, R. Lorenz, P. Born, 1996, Seminars in thrombosis and hemostasis.

Isolated upper pole access in percutaneous nephrolithotomy: a large-scale analysis from the CROES percutaneous nephrolithotomy global study.

M. Duvdevani, T. Esen, J. J. de la Rosette, 2013, The Journal of urology.

Lagerungstechniken in der Urologie

A. Gross, C. Netsch, J. Rassweiler, 2017, Der Urologe.

[Intrathoracic hernia after laparoscopic nephrectomy: clinical manifestation and conservative management].

E. Walthers, P. Olbert, A. Schrader, 2009, Der Urologe. Ausg. A.

CA 19 . 9 and CEA in Transitional Cell Carcinoma of the Bladder : Serological and Immunohistochemical Findings

P. Olbert, P. Barth, Z. Varga, 2010 .

[Endoscopic enucleation of the prostate].

A. Gross, C. Netsch, J. Rassweiler, 2019, Der Urologe. Ausg. A.

Female Gender Is an Age-dependent Negative Prognostic Factor for Patients with Upper Tract Urothelial Carcinoma.

H. Taubert, S. Wach, B. Wullich, 2015, Anticancer Research.

Metastatic non‐clear cell renal cell carcinoma: current therapeutic options

P. Olbert, A. Schrader, Z. Varga, 2008, BJU international.

897 High-dose ibandronate is effective and well tolerated in the treatment of pain and hypercalcaemia due to metastatic urologic cancer

P. Olbert, A. Heidenreich, A. Hegele, 2003 .

[Value of nerve growth factor levels in overactive bladder syndrome: alterations after botulinum toxin therapy].

P. Olbert, A. Hegele, R. Hofmann, 2012, Der Urologe (Ausg. A).

Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort

Y. Allory, I. Bièche, R. Stoehr, 2021, Journal of Clinical Pathology.

[Surgical positioning techniques in urology : Tips and tricks].

A. Gross, C. Netsch, J. Rassweiler, 2017, Der Urologe. Ausg. A.

Epithelial mesenchymal transition status is associated with anti-cancer responses towards receptor tyrosine-kinase inhibition by dovitinib in human bladder cancer cells

P. Olbert, J. Hänze, A. Hegele, 2013, BMC Cancer.

Combining Lithoclast and ultrasound power in one device for percutaneous nephrolithotomy: in vitro results of a novel and highly effective technology.

P. Olbert, A. Heidenreich, Z. Varga, 2003, Urology.

Urinary collecting system invasion in renal cell carcinoma: Incidence and long‐term prognosis

P. Olbert, A. Schrader, Z. Varga, 2009, International journal of urology : official journal of the Japanese Urological Association.

Giant Calculus of the Posterior Urethra following Recurrent Penile Urethral Stricture

P. Olbert, A. Heidenreich, S. Wille, 2002, Urologia Internationalis.

Biochemical Markers for Monitoring Response to Therapy: Evidence for Higher Bone Specificity by a Novel Marker Compared with Routine Markers

M. Karsdal, P. Qvist, P. Olbert, 2008, Cancer Epidemiology Biomarkers & Prevention.

[Predictors for presence of residual tumor in follow-up transurethral resection of bladder tumors: single center results].

P. Olbert, A. Hegele, R. Hofmann, 2013, Der Urologe. Ausg. A.